They won’t. Unless COVID makes a massive resurgence in Australia (unlikely at present) or they get it off the ground in the UK or USA, it will be another cellularity MOU........MIA. I don’t view this ethics approval as a serious attempt.... unless they can expand it to non COVID ARDS patients? Which would be the obvious and more rewarding route.
- Forums
- ASX - By Stock
- Ann: Ethics Approval to Commence Clinical Trial in COVID-19
They won’t. Unless COVID makes a massive resurgence in Australia...
-
- There are more pages in this discussion • 200 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.29M |
Open | High | Low | Value | Volume |
27.5¢ | 28.0¢ | 27.5¢ | $29.16K | 104.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 30669 | 26.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.0¢ | 44128 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 30669 | 0.265 |
2 | 80839 | 0.260 |
1 | 7698 | 0.255 |
1 | 50000 | 0.250 |
2 | 10000 | 0.245 |
Price($) | Vol. | No. |
---|---|---|
0.280 | 44128 | 1 |
0.290 | 16480 | 1 |
0.295 | 10160 | 1 |
0.305 | 20000 | 1 |
0.310 | 13257 | 2 |
Last trade - 13.07pm 26/06/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |